Senators call on FDA to act against misleading weight-loss drug commercials

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out the advertisement of prescriptions for injectable weight-loss drugs without disclosing safety and risk information.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup